#XLV

Last 24h 📉 Bearish 📉1

Last 7 Days 📉 Bearish 📉2 📊1

Last 30 Days 📉 Bearish 📉2 📊1

📊 ETF IBB 📉 Bearish

Trump’s FDA Commissioner Is Resigning With Agency in Turmoil

May 12, 2026 (20 hours ago)

FDA Commissioner Marty Makary’s resignation throws the agency into turmoil, threatening drug approvals and pressuring biotech and healthcare stocks.

▼ FDA Commissioner Makary resigns

📅 Short 🌍 US Read More →

📈 Stocks UNH 📊 Neutral

May 10, 2026 (3 days ago)

UnitedHealth Group (UNH) offers a discounted entry via options strategies despite analyst Mike Khouw’s reluctance to buy the stock outright, as the…

→ Options market pricing suggests a potential discount for UnitedHealth shares

📅 Short 🌍 US Read More →

📈 Stocks XLV 📉 Bearish

May 8, 2026 (4 days ago)

FDA gridlock clouds drug approval timelines, pressuring healthcare stocks and ETFs like XLV and IBB.

▼ Escalating reports of FDA dysfunction deepen sector uncertainty.

📅 Short 🌍 US Read More →